Patents by Inventor Durba Pal

Durba Pal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for reprogramming somatic cells into induced vasculogenic cells
    Patent number: 11578107
    Abstract: Disclosed herein are compositions and methods that involve using compositions containing one or more of ETV2, FOXC2, FLI1 and a miR-200b inhibitor for directly reprogramming somatic cells into induced vasculogenic cells both in vitro and in vivo. These compositions and methods are useful for a variety of purposes, including the development of pro-angiogenic therapies.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: February 14, 2023
    Assignee: Ohio State Innovation Foundation
    Inventors: Daniel Gallego-Perez, Ly James Lee, Durba Pal, Subhadip Ghatak, Chandan Sen
  • Compositions and methods for reprogramming somatic cells into induced vasculogenic cells
    Patent number: 11518790
    Abstract: Disclosed herein are compositions and methods that involve using compositions containing one or more of ETV2, FOXC2, FLI1 and a miR-200b inhibitor for directly reprogramming somatic cells into induced vasculogenic cells both in vitro and in vivo. These compositions and methods are useful for a variety of purposes, including the development of pro-angiogenic therapies.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: December 6, 2022
    Assignee: Ohio State Innovation Foundation
    Inventors: Daniel Gallego-Perez, Ly James Lee, Durba Pal, Subhadip Ghatak, Chandan Sen
  • COMPOSITIONS AND METHODS FOR REPROGRAMMING SOMATIC CELLS INTO INDUCED VASCULOGENIC CELLS
    Publication number: 20200115425
    Abstract: Disclosed herein are compositions and methods for directly reprogramming somatic cells into induced vasculogenic cells both in vitro and in vivo. These compositions and methods are useful for a variety of purposes, including the development of pro-angiogenic therapies.
    Type: Application
    Filed: December 20, 2017
    Publication date: April 16, 2020
    Inventors: Daniel Gallego-Perez, Ly James Lee, Durba Pal, Subhadip Ghatak, Chandan Sen